VWF and COVID-19: The thromboembolic complications of COVID-19 can be monitored by comparing the elevated levels of D-dimers, the fibrinogen, and the vWF with the normal ranges of PT, aPTT, and platelet count (Helms et al., 2020; Iba et al., 2020).